{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:45:35Z","timestamp":1789469135873,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07099-6","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:26:49Z","timestamp":1781141209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera"],"prefix":"10.1007","volume":"105","author":[{"given":"Elisabetta","family":"Cerchiara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Vozella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Luigi","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Iovene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele Maria","family":"Barsotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Ristori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Rigacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Angeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"7","key":"7099_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"issue":"11","key":"7099_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP et al (2022) International consensus classification of myeloid neoplasms and acute leukemia: integrating morphological, clinical, and genomic data. Blood 140(11):1200\u20131228","journal-title":"Blood"},{"key":"7099_CR3","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg P, Karow A, Nienhold R, Looser R, Hao Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC (2014) Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 123:2220\u20132228. https:\/\/doi.org\/10.1182\/blood-2013-11-537167","journal-title":"Blood"},{"issue":"16","key":"7099_CR4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood.2022017578","volume":"141","author":"D Luque Paz","year":"2023","unstructured":"Luque Paz D, Kralovics R, Skoda RC (2023) Genetic basis and molecular profiling in myeloproliferative neoplasms. Blood 141(16):1909\u20131921. https:\/\/doi.org\/10.1182\/blood.2022017578PMID: 36347013; PMCID: PMC10646774","journal-title":"Blood"},{"key":"7099_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/1eu.2014.3","volume":"28","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH, Maffioli M, Caramazza D, Passamonti F, Pardanani A (2014) CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 28:1472\u20131477. https:\/\/doi.org\/10.1038\/1eu.2014.3","journal-title":"Leukemia"},{"key":"7099_CR6","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","volume":"123","author":"E Rumi","year":"2014","unstructured":"Rumi E, Pietra D, Ferretti V, Klampfl T, Harutyunyan AS, Milosevic JD, Them NC, Berg T, Elena C, Casetti IC, Milanesi C, Sant\u2019antonio E, Bellini M et al (2014) JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood 123:1544\u20131551. 10.1182\/ blood-2013-11-539098","journal-title":"Blood"},{"issue":"1","key":"7099_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/bjh.13076","volume":"168","author":"AP Trifa","year":"2015","unstructured":"Trifa AP, Popp RA, Cucuianu A et al (2015) CALR versus JAK2 mutated essential thrombocythemia \u2013 a report on 141 patients. Br J Haematol 168(1):151\u2013153. https:\/\/doi.org\/10.1111\/bjh.13076","journal-title":"Br J Haematol"},{"issue":"9","key":"7099_CR8","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/leu.2014.76","volume":"28","author":"P Guglielmelli","year":"2014","unstructured":"Guglielmelli P, LashoTL, Rotunno G et al (2014) The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. Leukemia 28(9):1804\u20131810","journal-title":"Leukemia"},{"key":"7099_CR9","doi-asserted-by":"crossref","unstructured":"Vannucchi AM, Lasho TL, Guglielmelli P Mutations and prognosis in primary Luque, Paz D, Kralovics R, Skoda RC et al (2023) Genetic basis and molecular profiling in myeloproliferative neoplasms. Blood 141(16):1909\u20131921myelofibrosis. Leukemia. 2013;27(9): 1861\u20131869","DOI":"10.1182\/blood.2022017578"},{"issue":"19","key":"7099_CR10","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1182\/bloodadvances.2020002271","volume":"4","author":"D Luque Paz","year":"2020","unstructured":"Luque Paz D, Jouanneau-Courville R, Riou J et al (2020) Leukemic evolution of polycythemia Vera and essential thrombocythe mia: genomic profiles predict time to transformation. Blood Adv 4(19):4887\u20134897","journal-title":"Blood Adv"},{"key":"7099_CR11","doi-asserted-by":"publisher","first-page":"106787","DOI":"10.1016\/j.leukres.2022.106787","volume":"113","author":"Y Kusne","year":"2022","unstructured":"Kusne Y, Xie Z, Patnaik MM (2022) Clonal hematopoiesis: molecular and clinical implications. Leuk Res 113:106787","journal-title":"Leuk Res"},{"key":"7099_CR12","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1182\/blood-2014-06-583161","volume":"124","author":"J Broseus","year":"2014","unstructured":"Broseus J, Park JH, Carillo S, Hermouet S, Girodon F (2014) Presence of calreticulin mutations in JAK2-negative polycythemia vera. Blood 124:3964\u20133966. 10.1182\/ blood-2014-06-583161","journal-title":"Blood"},{"key":"7099_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bjh.12969","volume":"167","author":"G McGaffin","year":"2014","unstructured":"McGaffin G, Harper K, Stirling D, McLintock L (2014) JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort. Br J Haematol 167:276\u2013278. https:\/\/doi.org\/10.1111\/bjh.12969","journal-title":"Br J Haematol"},{"key":"7099_CR14","doi-asserted-by":"publisher","first-page":"57036","DOI":"10.18632\/oncotarget.10958","volume":"7","author":"MG Kang","year":"2016","unstructured":"Kang MG, Choi HW, Lee JH et al (2016) Coexistence of JAK2 and CALRmutations and their clinical implications in patients with essential thrombocythemia. Oncotarget 7:57036\u201357049","journal-title":"Oncotarget"},{"issue":"4","key":"7099_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/genes12040559","volume":"12","author":"TV Makarik","year":"2021","unstructured":"Makarik TV, Abdullaev AO, Nikulina EE et al (2021) Low JAK2 V617F allele burden in Ph-Negative chronic myeloproliferative neoplasms is associated with additional CALR or MPL gene mutations. Genes (Basel) 12(4):559","journal-title":"Genes (Basel)"},{"issue":"8","key":"7099_CR16","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3109\/10428194.2015.1116122","volume":"57","author":"O Mansier","year":"2016","unstructured":"Mansier O, Migeon M, Etienne G, Bidet A, Lippert E (2016) JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens. Leuk Lymphoma 57(8):1949\u20131951","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07099-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07099-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07099-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:43:04Z","timestamp":1789465384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07099-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7099"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07099-6","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient prior to study participation.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"373"}}